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Many pharmacologically important natural products
are assembled by modular type I polyketide syn-
thases (PKS), which typically act in a unidirectional
fashion. The synthases producing the unusual nitro-
substituted polyketides neoaureothin (nor, also
called spectinabilin) and aureothin (aur) are excep-
tional, as they employ individual modules iteratively.
Here, we investigate the plasticity of the nor PKS
and the factors governing the number of elongations
catalyzed by the noncanonical module. Surprisingly,
we observe that the nor PKS can mediate an addi-
tional chain elongation to yield the higher homolog
homoneoaureothin. Furthermore, we design several
truncated variants of the nor PKS to use them in the
context of artificial assembly lines for aureothin and
homoaureothin. The resulting polypropionate deri-
vatives provide valuable insights into chain length
control and reveal structure-activity relationships
relating to the size of the polypropionate backbones.
Overall, we show that iterative modules are remark-
ably adaptable while downstream modules are gate-
keepers that select for correct polyketide chain
length.
INTRODUCTION
Bacterial modular type I polyketide synthases (PKS) are giant
multifunctional enzymes that are responsible for the biosyn-
thesis of many pharmacologically relevant polyketides. These
diverse multienzyme systems efficiently synthesize highly com-
plex polyketide metabolites from simple acyl and malonyl units
(Fischbach and Walsh, 2006; Hertweck, 2009; Khosla et al.,
2009). In general, each PKS module minimally contains a keto-
synthase (KS), catalyzing the Claisen condensation of activated
acyl and malonyl units, an acyl transferase (AT) for selecting the
extender unit, and an acyl-carrier protein domain (ACP), to
which the acyl chain is tethered. After every chain elongation,
the b keto group may be optionally processed by ketoreduc-
tase, dehydratase (DH), and enoyl reductase (ER) domains.Chemistry & Biology 22, 229Finally, a thioesterase (TE) domain typically off loads the fully
elongated polyketide chain from the enzyme complex. As a
result of the unidirectional assembly, the number and architec-
ture of the modules typically corresponds with the structure
of the polyketide backbone. This rule of colinearity has been
employed to rationalize the evolution of metabolic diversity, as
it is very conceivable that the acquisition or duplication, rear-
rangement, and deletion of domains and entire modules have
changed the program of polyketide assembly (Jenke-Kodama
et al., 2006, 2005; Nguyen et al., 2008). This biosynthetic
concept has set the basis for rationally engineering polyketide
metabolites (Poust et al., 2014; Weissman and Leadlay, 2005;
Wong and Khosla, 2012) and to predict polyketide structures
from PKS gene sequences (Challis, 2008; Helfrich et al., 2014;
Winter et al., 2011).
Nonetheless, several modular PKSs act in a noncolinear
fashion. Congeners of the main polyketide products have been
isolated that point to the accidental skipping of individual do-
mains or the iterative use of modules (Hardt et al., 2001; Wilkin-
son et al., 2000). Apart from such error-prone PKSs that lack
fidelity, a growing number of modular PKSs have been reported
that breach the rule of colinearity; in such noncanonical assem-
bly lines, the iterative use of individual PKS components has
been shown to be a programmed event (Moss et al., 2004). First
indications for an iterative use of modules in a modular assembly
linewere gained by analysis of the biosynthetic codes for stigma-
tellin (Gaitatzis et al., 2002), borrelidin (Olano et al., 2003, 2004),
and aureothin (He and Hertweck, 2003, 2005). Noncolinear type I
PKSswere also identified in the biosynthetic pathways leading to
lankacidin (Arakawa et al., 2005), neocarzilin (Otsuka et al.,
2004), and neoaureothin (Traitcheva et al., 2007), and more
recently, cryptic PKS programming was revealed for the etnan-
gien (Menche et al., 2008) and crocacin (Mu¨ller et al., 2014)
PKSs. The possibility of duplicated gene products, which could
theoretically account for additional chain elongations, was ruled
out by PKS gene fusions that yielded the correct architectures of
borrelidin (Olano et al., 2003), aureothin (He and Hertweck,
2005), and lankacidin (Tatsuno et al., 2007). On the other hand,
when taken out of its natural context, a module of the colinear
picromycin PKS proved to be capable of catalyzing two rounds
of elongations (Beck et al., 2003). Furthermore, a ratchet mech-
anism seems to prevent the upstream movement of intermedi-
ates in colinear assembly lines such as the erythromycin PKS
(Kapur et al., 2012). Yet, the cause for iteration in modular,–240, February 19, 2015 ª2015 Elsevier Ltd All rights reserved 229
Figure 1. Structures of Nitrosubstituted Pyrone Metabolites from
Streptomyces spp.
The biosynthetic building blocks derived from p-nitrobenzoate, malonyl- and
methylmalonyl-coenzyme A are highlighted with bold lines. The waved bracket
indicates assembly of the substructure by a single module.noncolinear PKSs is only little understood and poses one of the
major riddles in polyketide biosynthesis.
The aureothin/neoaureothin family of polypropionates repre-
sents a versatile model system to address this issue. Neoaureo-
thin (also known as spectinabilin, 1) and aureothin (2) are unusual
nitroaryl-substituted pyrone metabolites from Streptomyces or-
inoci and Streptomyces thioluteus, respectively (Figure 1); they
share the same structural features and building blocks (He and
Hertweck, 2004; He et al., 2004; Mu¨ller et al., 2006a) and differ
solely in the size of the central polyene stretch (Busch and Hert-
weck, 2009). Through analysis of the neoaureothin (nor) and
aureothin (aur) biosynthesis gene clusters, gene fusions, muta-
genesis, and cross-complementation, we have found that the
diene moiety of 2 is generated by an iteratively acting module
(AurA) (He and Hertweck, 2003), whereas one iterative module
and two noniterative modules assemble the tetraene backbone
of 1 (Figure 2A) (Traitcheva et al., 2007). In silico analyses of
the aur and nor PKSs indicated that the aur PKS has evolved
from the nor PKS by gene deletion. This model is supported by
the successful cross-complementation experiments of the first
modules, which proved to be functionally equivalent (Traitcheva
et al., 2007). Mutational studies revealed themechanism of inter-
mediate retrotransfer from one polypeptide strand of the PKS
homodimer onto the other (Busch et al., 2012). Module iteration
was also observed in an artificial luteoreticulin (3) (lut) PKS ob-
tained through redesign of the aureothin PKS (Sugimoto et al.,
2014). Notably, the lowest homolog, orinocin (4), is not generated
by an even smaller PKS but results from a photoinduced polyene
splicing of 1 (Mu¨ller et al., 2006b).
Whereas in the intact aur, lut, and nor PKS systems, the first
module catalyzes two rounds of elongations, the freestanding
module is even capable of triple and quadruple iterations (Fig-
ure 2B) (Busch et al., 2013). This finding implies that multiple
factors control whether a module iterates or not, and it was pro-
posed that kinetic factors and the substrate specificity of the
downstreammodules could play key roles in noncolinear assem-
bly lines (Busch et al., 2013).
Here, we report the successful heterologous reconstitution of
the noncolinear neoaureothin PKS and several rationally de-
signed assembly lines, which not only provided new insights
into the regulation of neoaureothin biosynthesis but also yielded
two missing members of the (neo)aureothin family. Beyond
providing structure-activity relationships regarding the size of230 Chemistry & Biology 22, 229–240, February 19, 2015 ª2015 Elsethe polypropionate backbone, these data reveal a remarkable
adaptability of iterative modules and a rather rigid gatekeeping
by downstream modules to control polyketide assembly.
RESULTS AND DISCUSSION
Reconstitution and Heterologous Expression
of the nor PKS
To gain a deeper insight into the noncolinear PKS systems and
their evolution, we aimed at the heterologous expression and
targeted manipulation of the nor biosynthetic gene cluster. Frag-
ments of the neoaureothin biosynthesis gene cluster were
located on two cosmids, pSO1A9 and 24D5, in a library of Strep-
tomyces orinoci total DNA fragments (Traitcheva et al., 2007)
(Figure 3A). Since recombination-based fusion experiments led
to unwanted results such as rearrangements, a two-plasmid sys-
tem was employed for the heterologous expression of the gene
cluster. A large fragment covering most nor genes (norD-B; from
pSO1A9) was cloned into E. coli-Streptomyces shuttle vector
pKJ01 (Jakobi and Hertweck, 2004), and the gene cassette
norBCI (from pSO24D5) was cloned into the pKJ55 vector (Ishida
et al., 2007) downstream of the constitutive ermE* promoter. The
resulting clones, pNT40 and pNT42, were introduced into the
expression host (S. lividans ZX1). However, no neoaureothin pro-
duction was detected by high-performance liquid chromatog-
raphy (HPLC)-mass spectrometry (MS) analysis of the culture
broth.
Transcription and metabolic analyses suggested that genes
under the control of the constitutive ermE* promoter were ex-
pressed, whereas genes under the control of the natural regula-
tory system were downregulated. This finding is not surprising,
as the putative regulator of the nor gene cluster, NorD, is similar
to the transcriptional repressor ArsR (Bairoch, 1993). Thus, to
induce gene expression, we performed an in-frame deletion of
norD by PCR targeting. The resulting plasmid, pNT87, was intro-
duced into S. lividans ZX1::pNT42. Unexpectedly, the mutant
strain did not produce any neoaureothin either, which pointed
to a more complex regulation.
By inspection of the flanking regions of the nor gene locus, we
found two additional genes, norR and norZ, which might be
involved in regulation and resistance, upstream of the gene
cluster. NorR is related to transcriptional activators of the AfsR
family, whereas norZ likely encodes a transporter of the major
facilitator superfamily. In order to investigate whether these
two genes were involved in the regulation of the neoaureothin
pathway, they were excised from cosmid pSO20D4 and cloned
into pBU12, an SCP2*-based self-replicating vector derived from
pRM5 (McDaniel et al., 1993). The resulting plasmid (pBU145)
was introduced into S. lividans::pNT42/pNT40. HPLC-MS anal-
ysis of themetabolic profile of themutant showed that neoaureo-
thin was produced, albeit only in trace amounts.
To improve neoaureothin production, we sought to upregulate
gene expression using a genuine regulatory system and turned
to the working aur gene expression constructs. The aur gene
cluster harbors a putative transcriptional regulator gene (aurD)
(Figure 3A) (He and Hertweck, 2003). Unlike NorD, AurD shows
sequence similarity to transcriptional activators of the AfsR fam-
ily (Horinouchi et al., 1990). Given the similarities of the aur and
nor gene cluster sequences, we postulated that coexpressionvier Ltd All rights reserved
Figure 2. Iterative Modules in the nor and aur Assembly Lines
(A) Model for neoaureothin assembly by the noncolinear nor PKS.
(B) The first module can catalyze up to four elongations when taken out of the biosynthetic context.of aurD could activate the nor gene cluster in the absence of
norD. To test this hypothesis, we constructed an aurD expres-
sion plasmid. The activator gene was cloned into pBU12 down-
stream of the actII-ORF4 promoter, and the resulting plasmid
(pYU1) was introduced into S. lividans ZX1 together with
pNT42 and pNT87. The HPLC profile of the resulting strain
(S. lividans ZX1::pNT42/pNT87/pYU1) showed neoaureothin
production at substantially increased titers (15 mg l1) (Fig-
ure 4A). Although the amount of neoaureothin produced by het-
erologous expression is lower than in the wild-type producer
S. orinoci (90 mg l1), the production rate was dramatically
improved in comparison with any of the other mutants.
Our findings are also intriguing from an evolutionary point of
view. Analysis of the spectinabilin biosynthesis gene cluster
from S. spectabilis (Choi et al., 2010) revealed a high sequence
identity to both the aureothin and neoaureothin PKS genes.
Moreover, the regulator gene was highly homologous to aurD,Chemistry & Biology 22, 229whichmay indicate that the spectinabilin biosynthesis gene clus-
ter could represent an evolutionary link between the nor and aur
gene clusters. A plausible scenario would be the replacement of
norDwith an aurD-like gene encoding a transcriptional activator.
Thereafter, the PKS geneswould be rearranged to yield a shorter
type I PKS.
Discovery of a Neoaureothin Homolog Produced
by the nor PKS
The successful heterologous production of neoaureothin not only
set the stage for pathway engineering experiments. When in-
specting themetabolic profile of the heterologousproducer strain,
we unexpectedly noted that small amounts (0.025 mg l1) of
a novel metabolite (5) are formed. The high-resolution MS spec-
trum revealed that 5 has the molecular formula C31H36NO6.
Comparison of the 1H nuclearmagnetic resonance (NMR) spectra
of 1 and 5 showed one additional couple of olefinic and methyl–240, February 19, 2015 ª2015 Elsevier Ltd All rights reserved 231
Figure 3. Comparison of Three Homolo-
gous Biosynthetic Gene Clusters and Stra-
tegic Plan for Engineering the nor PKS
Pathway
(A) Organization of neoaureothin (nor), spectina-
bilin (spn) and aureothin (aur) biosynthesis gene
clusters.
(B) Reconstitution and activation of the nor gene
cluster using three plasmids. Each arrow indicates
the direction of transcription and relative sizes of
the open reading frames. Deduced gene products:
NorA-C, PKS; NorD, transcriptional regulator;
NorE, acyl-coenzyme A ligase; NorF, N-oxygen-
ase; NorG, p-aminobenzoic acid synthase; NorH,
cytochrome P450 monooxygenase; NorI, methyl-
transferase; NorJ, unknown; NorR (putative AfsR-
like regulator); NorZ (transporter major facilitator
superfamily).
(C) Traceless PKS gene cloning/engineering
strategy to construct aur* and aur# PKSs.proton signals of 5. In addition, proton signals typical for aureo-
thin-type polyketides were observed, such as two doublets of
aromatic protons (H20/H24, d 7.42, and H21/H23, d 8.18) of the
p-nitrobenzoate moiety, methoxy protons (H2a, d 3.92) of the py-
rone ring, and the hydroxyl methylene protons (H9a, d 4.68 and
4.80) of the furan ring. 13C NMR, distortionless enhancement by
polarization transfer (DEPT), and heteronuclear single quantum
coherence (HSQC) spectra rigorously supported that 5 is a
homolog of 1 and was thus named homoneoaureothin (5). Heter-
onuclear multiple bond correlation (HMBC) correlations between
methoxy protons H2a (d 3.92) and C2 (d 162.1), methyl protons
H3a (d 1.83) and C2, C3 (d 99.9), C4 (d 180.6), and methyl protons
H5a (d 2.01) and C4, C5 (d 119.9), C6 (d 155.1) established the
g-pyrone ring configuration (Supplemental Information). The E
(C11–C18) and Z (C9) configurations were inferred from nuclear
Overhauser effect spectroscopy (NOESY) data. Its absolute
configuration was deduced from comparisons of CD spectra of
5, 1, and 2, which all show similar curve shapes (Supplemental
Information).232 Chemistry & Biology 22, 229–240, February 19, 2015 ª2015 Elsevier Ltd All rights reservReinvestigation of the wild-type me-
tabolome by HPLC-MS revealed that
traces of 5 are also formed in the
genuine PKS system, but this com-
pound was previously overlooked
because of the metabolic background
of S. orinoci. The discovery of 5 is
intriguing, as the structure of the pen-
taene implies an additional iterative use
of a PKS module. In principle, it would
be conceivable that the additional chain
elongation was mediated by one of the
downstream modules (module 2 or 3),
which have a similar architecture to the
iterative module 1. However, using the
NorA homolog AurA as a standalone
PKS component of the aureothin PKS,
we have recently demonstrated that
iteration of the first module is not
restricted to two elongations; it canalso generate longer chains, which result from three or even
four elongations (Busch et al., 2013). NorA is functionally
equivalent to AurA, and we have demonstrated by cross-
complementation that NorA can even replace AurA to yield a
functional aur PKS. Thus, it is more likely that NorA catalyzes
three rounds of chain elongations, and the intermediate is then
elongated by each module 2 and 3 in a colinear fashion to yield
the pentaene.
Morphing of the nor PKS into Artificial aur PKS-like
Assembly Lines
The nor and aur PKS exhibit similar architectures, and the multi-
ple use of the first module raised the question whether it could be
possible to generate aur PKS-like systems from the nor PKS that
produce either neoaureothin or aureothin. In fact, bioinformatics
analyses suggest that the aur and nor genes have an evolu-
tionary relationship. According to the phylogeny, the most parsi-
monious scenario is that the aureothin biosynthesis gene cluster
evolved from the nor gene locus through loss of norA0 (Traitchevaed
Figure 4. HPLC Monitoring of Metabolic Profiles of Pathway Engi-
neered Mutants, Heterologous Host Strain, and Authentic Neoaur-
eothin and Chemical Structures of Novel Metabolites Produced by
the Mutants
(A) HPLC profiles (UV 254 nm) of culture extract from heterologous neo-
aureothin producer (S. lividans ZX1::pNT42/pNT87/pYU1) (a), heterologous
homoaureothin producer (S. lividans ZX1::pNT42/pYU50/pYU1) (b), heterolo-
gous host strain (S. lividans ZX1) (c), and authentic neoaureothin reference (d).
Peaksmarkedwith asterisks are derived from the E/Z isomers of compounds 1
in (a) and (d) and 6 in (b).
(B) Chemical structures of the novel metabolites from the pathway engineered
mutants, homoneoaureothin (5) and homoaureothin (6). Selected HMBC and
COSY correlations are indicated by arrows and bold lines, respectively.et al., 2007). To test this hypothesis and to emulate this evolu-
tionary scenario, we constructed several truncated neoaureothin
assembly lines.
First, we sought to generate an aur PKS from the nor PKS. To
formally achieve this goal, modules 2 and 3 were excised. How-Chemistry & Biology 22, 229ever, as it was deemed necessary to maintain the appropriate
ACP-KS docking domain regions (Weissman, 2006) and the
substrate specificity of KS2, the boundaries between the KS
domains and KS-AT linkers in modules 2 and 4 were chosen
as fusion sites (Figure 5). The corresponding gene region was
substituted with a spectinomycin resistance cassette (addA)
flanked by HpaI restriction sites by PCR targeting. After
successful recombination of the targeted gene region in
Escherichia coli, the cassette was removed by digestion with
HpaI and subsequently religated to generate the seamless
fusion (Figure 3C). The resulting construct encoding the aur*
PKS (pYU48 together with pNT42 and pYU1) was introduced
into S. lividans for heterologous expression. The culture ex-
tracts of various cultures of verified transformants were moni-
tored by HPLC-MS, but aureothin production could not be
detected.
There are various possible reasons for the inability of the aur*
PKS mutant to produce aureothin. The engineered PKS
could be nonfunctional because of misfolding of the chimeric
polypeptide, and the interaction between the KS and ACP do-
mains could be suboptimal, which might hamper polyketide
assembly (Hans et al., 2003). Since related constructs were
functional, a more plausible explanation would involve the func-
tion and substrate specificities of the PKS modules. The first
four nor PKS modules can biosynthesize hexa- and heptaketi-
des, which are further extended by modules 5 and 6 to yield
tetraene 1 and pentaene 5. In the aur* PKS, module 1 and
hybrid module 2/4 would primarily produce a tetraketide, which
is likely not accepted as a substrate of the downstream KS5
domain.
Next, we sought to generate an aur-like PKS to test whether
or not the iterating first module could compensate for two
missing downstream modules (aur# PKS). Therefore, we deleted
norA0 and fused the KS2 docking domain to KS4 (Figure 5). In
this construct, the overall PKS architecture would be the same
as in the aur and aur* PKS, but the formation of neoaureothin
would be expected because of the different KS specificity. To
construct the aur# fusion PKS, the same method as for the
aur* PKS construction was employed, except for the used re-
striction site (AvrII). The gene region encoding from KS2 to
KS4 except for the N-terminal linker of module 2 was substituted
with an extended spectinomycin resistance cassette flanked by
AvrII restriction sites in E. coli. After recombination, the cassette
was removed by AvrII digestion and religation to yield the
aur# PKS gene (Figure 5). The recombinant expression plas-
mid (pYU69) was then introduced into S. lividans together
with pNT42 and pYU1. By HPLC analysis of the aur# PKS mu-
tant culture, neither neoaureothin nor its homologs could be
detected.
We demonstrated earlier that AurA is capable of producing
polyketides with up to four propionate units, at least as a free-
standing enzyme (Busch et al., 2013). The in vivo experiments
above indicated that the functionally equivalent first module of
the nor PKS (NorA) can produce intermediates with diene and
even triene backbones. In principle, the pentaketide should be
accepted by KS4, as shown in the heterologously reconstituted
full-length nor PKS. Yet, apparently, the tetraene is not formed in
the context of the PKS complex or the titers are too low to allow
for the detection of the final product, and the shorter polyketide–240, February 19, 2015 ª2015 Elsevier Ltd All rights reserved 233
Figure 5. Domain Organization of nor PKS, Engineered nor PKSs, aur*, aur#, and har PKS, and their Deduced Intermediates
234 Chemistry & Biology 22, 229–240, February 19, 2015 ª2015 Elsevier Ltd All rights reserved
chains are not to be processed further by the KS4 domain of the
aur# PKS.
Rational Design of a Missing Member of the Aureothin
Family
The two constructs described above indicate that the lack of two
modules cannot be compensated by the engineered assembly
lines. Thus, we aimed at generating a truncated assembly line
lacking only a single module to further evaluate the plasticity of
the nor PKS. Specifically, we sought to design a truncated as-
sembly line that would yield a nonnatural congener with a triene
backbone, homoaureothin (6), the missing member of the aureo-
thin family of polypropionates.
For the construction of a homoaureothin-forming (har) PKS,
the gene region coding for regions between the KS of module
2 and the KS-AT linker in module 3 were deleted from the nor
PKS gene by PCR targeting. The corresponding gene region
was substituted with a spectinomycin resistance cassette
franked by HpaI restriction sites. After successful replacement
of the targeted gene region in E. coli, the cassette was removed
by digestion with HpaI and religated to generate a seamless
fusion. The resulting plasmid (pYU50) (Figure S3) was introduced
into the heterologous host S. lividans ZX1 harboring pNT42 and
pYU1. By HPLC-MS monitoring of the fermentation broth of the
recombinant strain, we observed the production of a novel com-
pound (6, 0.33 mg l1), and high-resolution MS (HRMS) revealed
the expected molecular formula of C25H27NO6 for homoaureo-
thin (Figure 4).
Compound 6 was isolated from the mycelium and culture
broth of a 20 l fermentation and purified by open column chroma-
tography, followed by preparative HPLC. 1H NMR, 13C NMR,
1H-1H correlation spectroscopy (COSY), and HSQC spectral an-
alyses corroborated the presence of a p-nitrobenzoate moiety,
furan ring, and pyrone ring and confirmed that 6 lacks one double
bond comparedwith neoaureothin. HMBC correlations ofmethyl
protons H2a (d 3.91), H3a (d 1.82), H5a (d 1.99), H11a (d 2.01),
H13a (d 2.03), hydroxyl methine proton H7 (d 5.09), hydroxyl
methylene protons H9a (d 4.69, 4.81), and the olefinic proton
H14 (d 6.39) to adjacent carbons fully support the proposed
structure of 6 (Supplemental Information). The E (C11–C14)
and Z (C9) configurations were deduced from NOESY data,
and comparison of CD spectra showed that the absolute config-
uration at C7 is the same as in the congeners. Thus, we have
successfully morphed the nor assembly line into a PKS that pro-
duces homoaureothin.
Furthermore, by thorough liquid chromatography (LC)-HRMS
examination of the metabolic profile of the homoaureothin-pro-
ducing mutant and comparison with an authentic reference, we
also detected trace amounts of neoaureothin (Figure 4A). The
formation of the tetraene-bearing product can be explained
only by an additional module iteration to compensate for the
lack of the third module. This finding also supports the model
of homoneoaureothin formation involving an additional iteration.
Iteration Versus Gatekeeping
The metabolic engineering of the neoaureothin assembly line
and the isolation of new aureothin/neoaureothin members
(5 and 6) teach us a lesson on freedom and constraint in nonco-
linear assembly lines. We have shown that the KS domains in norChemistry & Biology 22, 229PKS modules can accept and process polyketide intermediates
that are either longer or shorter than the genuine substrate.
Although relaxed substrate specificities of KS domains have
been previously observed in colinear systems (Khosla et al.,
1999), it is an important finding for understanding polyketide pro-
cessing in noncolinear systems. Considering the ability of the
iterative nor or aur PKS modules to catalyze two to four elonga-
tions, the downstreammodules apparently accept intermediates
only within a particular size range. Nonetheless, the gatekeeping
does not seem to be affected by different sizes of polyketide
starter units in the native aur PKS (Ziehl et al., 2005; Werneburg
et al., 2010).
Although dramatically reduced or even fully abolished polyke-
tide productions may result from suboptimal fusion sites in
modular PKS (Kellenberger et al., 2008; McDaniel et al., 1999),
we may exclude this possibility, because the constructs were
carefully checked and the same sites were used in the functional
har PKS and other functional constructs such as the artificial lut
PKSs (Sugimoto et al., 2014). Beyond structural restrictions of
KS and intermediates, it is also conceivable that gatekeeping
involves both structural and kinetic factors. In a noncolinear sys-
tem such as the nor and aur PKSs, there is competition between
the speed of retrotransfer to the upstream KS and chain propa-
gation onto the downstream module as well as loading of the
KS1 domain with the starter unit. Obviously, the number of elon-
gations is influenced by the biosynthetic context of the specific
iterative module. NorA has the freedom to compensate for one
(but not two) lacking modules as in the har PKS, and the number
of iterations and chain propagations are restricted by the down-
stream modules, as in the aur* and aur# PKS. Thus, we can
deduce that besides the size control of iterative modules, there
is a gatekeeping function of the downstream KS to select for
the correct substrates.
Impact of Polypropionate Chain Length on Antimicrobial
and Antiproliferative Activities
Having the diene, triene, tetraene, and pentaene congeners at
hand for the first time, we examined the impact of the size of
the polyketide backbone on bioactivities. Using whole-cell as-
says we analyzed the antimicrobial, cytotoxic, and antiprolifera-
tive activities of the pyrones. Moderate antibacterial activities
were observed for 2 (Bacillus subtilis) and 6 (Staphylococcus
aureus, methicillin-resistant S. aureus [MRSA]) (Figure 6). How-
ever, in general, the pyrones exhibit a remarkable selectivity
with respect to antifungal activities. Among the compounds
and strains tested, a clear trend is visible. Whereas tetraene
and pentaene are only moderately active against the representa-
tive test strains (Candida albicans, Penicillium notatum, and
Sporobolomyces salmonicolor), the triene is substantially more
active. The shortest congener, aureothin (2), shows strongest
activities against fungi and yeasts in the agar diffusion assay,
which is clearly superior to the reference compound ampho-
tericin (Figure 6A). Surprisingly, the situation is reversed with
respect to the antiproliferative and cytotoxicity assays using
K-562 (myelogenous leukemia) and HUVEC (human umbilical
vein endothelial cell) cell lines. It is remarkable that the longest
polypropionate, homoneoaureothin (5), exhibits the most pro-
nounced antiproliferative and cytostatic activities of the four py-
rones (Figure 6B). Overall, the pyrones show an unusually flat–240, February 19, 2015 ª2015 Elsevier Ltd All rights reserved 235
Figure 6. Survey on Antimicrobial and Anti-
proliferative Effects of Neoaureothin 1 and
Aureothin 2 and Homologs, Homoneoaur-
eothin 5 and Homoaureothin 6
(A) (a)Antifungal activity against Sporobolomyces
salmonicolor, Candida albicans, and Penicillium
notatum. (b) Antibacterial activity against Bacillus
subtilis, Staphylococcus aureus (MRSA), and
Mycobacterium vaccae. Am, amphotericin B; Cp,
ciprofloxacin (inhibition zone in mm).
(B) Cytostatic effect of neoaureothin 1, aureothin 2,
homoneoaureothin 5, and homoaureothin 6 on (a)
K-562 (myelogenous leukemia) cells and (b)
HUVEC. Cells were seeded on the microplate well.
After 72 hr incubation, the relative amount of
treated cells was monitored versus the control
(bold line).dose-response curve. These results illustrate that the size of the
polypropionate backbone has a clear impact on the biological
activities of the pyrone natural products. It would be necessary
to consider these findings when designing either antifungal or
antiproliferative agents that are inspired by (neo)aureothin-type
compounds.
SIGNIFICANCE
Modular PKSs play amajor role in the production of pharma-
ceutically relevant natural products. Understanding the
function of the typically unidirectional assembly lines en-
ables the rational design of novel synthases that lead to
structural analogs that are difficult to synthesize. The un-
conventional PKSs of the antifungal and antiproliferative py-
rones aureothin and neoaureothin constitute a remarkable
model to study factors controlling noncolinear polyketide
assembly and evolutionary processes that lead to structural
diversity. To redesign the neoaureothin synthase, we recon-
stituted the entire pathway in a heterologous host. Deletion
of a repressor gene and coexpression of an activator gene
from the related aureothin pathway not only led to dramati-
cally increased production titers but also provided insight
into a plausible evolutionary relationship of the gene clus-
ters. Refactoring the nor PKS into shorter modular PKS
systems, we rationally constructed a nonnatural polyketide
assembly line to produce a missing member of the neoaur-
eothin/aureothin family. Valuable insight into the plasticity
of the iterative modules was gained: an iterative module236 Chemistry & Biology 22, 229–240, February 19, 2015 ª2015 Elsevier Ltd All rights reservmay compensate for the loss of amod-
ule, albeit accompanied by a drop
down of productivity. While there is a
degree of flexibility in the system that
allows for one additional elongation, it
appears that downstream modules
are gatekeepers that select for the cor-
rect size of the polyketide chain. The
aur/nor PKSs are fine-tuned multien-
zyme systems that likely have been
selected for the biological activities of
the products. Access to four polypro-pionate homologs for the first time allowed analysis of the
structure-activity relationship with respect to the size of
the polyketide backbone. Remarkably, the longest congener
exhibits enhanced cytostatic effects, whereas antifungal ac-
tivity increases dramatically with shorter chain lengths.
Thus, the results from our pathway engineering approaches
may be useful not only for the field of synthetic biology or
combinatorial biosynthesis but also from a pharmacological
point of view.
EXPERIMENTAL PROCEDURES
Strains and Media
E. coli strain TOP10 (Invitrogen) and XL10-Gold (Stratagene) served for routine
subcloning. E. coli HB101/pRK2013 and E. coli BW25113/pIJ790 were
employed for triparental conjugation (Ditta et al., 1980) and for PCR targeting
procedures (Gust et al., 2003), respectively. E. coli strains were cultured in Lu-
ria-Bertani medium supplemented with ampicillin (100 mg ml1, Carl Roth),
apramycin (50 mgml1, Sigma-Aldrich), kanamycin (25 mgml1, Sigma), chlor-
amphenicol (25 mgml1, Roth), or spectinomycin (100 mgml1, Sigma-Aldrich)
for plasmid selection. S. lividans ZX1 (Zhou et al., 1988), kindly provided by
Prof. X. Zhou, was used as the host strain for heterologous expression exper-
iments. For metabolite production, Streptomyces mutant strains were grown
with orbital shaking at 28C in R5medium for 3 days. This seed culture (2 l) was
used to inoculate 20 l of the fermentationmedia, in modified R5medium (1 g of
casamino acids and without saccharose) in a stainless steel fermenter. After 3
to 4 days, fermentation was stopped. For sporulation, Streptomyces strains
were grown on 2CM (complete medium) or MS (mannitol soya flour) agar
plates. Conjugation was performed on MS agar supplemented with MgCl2
(10 mM) and overlaid next day with nalidixic acid (20 mg ml1, Carl Roth)
together with appropriate antibiotics. For protoplast transformation,
S. lividans strains were grown on YEME (yeast extract and malt extract)ed
or R5 medium and on R5 agar. Apramycin (30 mg ml1), spectinomycin
(400 mg ml1), and thiostrepton (5 mg ml1) were used for plasmid selection
in Streptomyces strains.
Plasmid and General DNA Procedures
DNA isolation, plasmid preparation, restriction digests, PCR, gel electropho-
resis, ligation reactions, and transformation were performed according to
standard methods for E. coli (Sambrook et al., 1989) and for Streptomyces
(Kieser et al., 2000). Restriction enzyme-digested and PCR-amplified DNA
fragments were purified from agarose gel by the GFX PCR DNA and Gel
Band Purification Kit (GE Healthcare) or Invisorb Spin DNA Extraction Kit (Invi-
tek). E. coli-Streptomyces shuttle vectors pSET152 (Bierman et al., 1992),
pKJ01 (Jakobi and Hertweck, 2004), and pKJ55 (Ishida et al., 2007) were
used for expression in Streptomyces strains.
Reconstitution of the nor PKS
Design of Expression Plasmids pNT40, pNT42, and pNT 87
About 35 kb SspI insert of cosmid 1A9, which contains the cos site, was recov-
ered and ligated into the SwaI site of the E. coli-Streptomyces shuttle vector
pKJ01, a pRM5 derivative, to give a plasmid pNT40. A 16 kb AfeI fragment
from cosmid 24D5, containing norB, C, and I was cloned into the EcoRV site
of the pKJ55 vector, a derivative of integrative E. coli-Streptomyces shuttle
vector pSET152, equipped with an ermE* promoter, yielding pNT42. Deletion
of norD in pNT40 was achieved by PCR targeting. The spectinomycin resis-
tance cassette flanked by FRT sites was amplified by PCR using two primers
norDL (50-TGA TTG GCG AAC TAC GAA TGG CTT CGT ACA ATG GGG GTG
ATT CCG GGG ATC CGT CGACC-30) and norDR (50-CGC TCA CCT TTG AAG
TCC CAT GGT ACT CCT GCG CGA TCA TGT AGG CTG GAC TGC TTC-30).
The replacement of norD with the extended cassette was accomplished in
E. coliBW25113/pIJ790 containing pNT40 by lRED-mediated recombination.
Thereafter, the cassette was removed by the expression of FLP recombinase.
The resulting plasmid was named pNT87.
Construction of aurD and norR/norZ Expression Plasmid
A 5.5 kb XbaI-PmlI fragment from pSO20D4 was inserted into XbaI-SwaI di-
gested pBU12 to give a plasmid pBU145. Plasmid pBU12 was generated by
ligation of the 1.4 kb HindIII-EcoRI fragments from pHGF7505 and a blunted
1.3 kb XbaI fragment from pIJ778 into the 11.8 kb HindIII-EcoRI and EcoRV
sites from pRM5, respectively. The active regulator gene, aurD, was amplified
as a 1.0 kb PacI-EcoRI fragment with two primers aurD_PacI_fw (50-TTA ATT
AAA TTC GCG AGA GAG GCG TAT-30) and aurD_EcoRI_rv (50-GAA TTC AAC
GGC AAG ATC CAG AAG G-30) from pHJ48 (He and Hertweck, 2003). The
PCR product was cloned into PacI-EcoRI-digested pBU12 to give a plasmid
pYU1.
Construction of aur* PKS Mutant
Cosmid pNT87 was reduced in size by means of PCR targeting. Two long
primers, pNT87_shrink_fw (50-ACC TTT ATG GAG GTG GGG CCG TCC
GGG ACG CTC ACC GCC ATG CAG TGG GCT TAC ATG GCG-30) and
pNT87_schrink_rv (50-GGG CGC CAT GCG TGG TCA CCA GGT GCC GGA
CCA CCA GAC GAC GCA GGA AAG AAC ATG TGA-30) were designed. A
2.7 kb PCR product was amplified from pCR2.1 TOPO as a template and
introduced into E. coli BW25113/pIJ790 harboring pNT87 and resulted in
construct pYU31. In order to delete the gene region encoding between AT2
and KS4 domains, two long primers KS2_fw_HpaI (50-AAC GCC CAT GTC
ATC CTG GAA CAG GCC GAG CAG CCC CCG GTT AAC GGA ACT TCG
AAG TTC CCG CC-30) and KS4_rv_HpaI (50-CGG GAT GTC CGC GCC CTC
CGG CCC GTC CGT CAT CTC CCC GTT AAC GGA ATA GGA ACT TCA
TGA GC-30) were designed and used to amplify a spectinomycin resistance
cassette flanked by HpaI restriction sites from pIJ778 as a template. Bound-
aries of KS2-AT2 linker and KS4-AT4 linker were chosen as fusion sites (Fig-
ure S2 available online). The PCR product was used to transform E. coli
BW25113/pIJ790 harboring pYU31. The replacement of the target gene re-
gion with the spectinomycin resistance cassette was achieved by l RED-
mediated recombination. A 2.3 kb StuI-EcoRI fragment from resulting
plasmid pYU34 was introduced into E. coli BW25113/pIJ790 containing
pNT87 and resulted in construct pYU47. pYU47 was digested with HpaI
and religated to remove the resistance cassette. Finally, the expression
plasmid pYU48 for aur* PKS was obtained.Chemistry & Biology 22, 229Construction of the aur# PKS Mutant
The aur# PKS mutant was constructed using a recombination strategy in anal-
ogy to the construction of the aur* PKS mutant. In order to delete gene region
encoding AurA0 except for the N-terminal linker, two long primers,
KS2_fw_HpaI_3 (50-GTG CAG ACC CGT GAA CGC CTG CGG ACC GCC
CAG GCG GCG CCT AGG GGA ACT TCG AAG TTC CCG CC-30) and
KS4_rv_HpaI_3 (50-GGG GAA GCG GCA GCC CAT GGC CAC CAC CGC
CACCGG TTCCCT AGGGGAATAGGA ACT TCA TGAGC-30) were designed
to amplify a spectinomycin resistance cassette flanked by AvrII restriction
sites. Boundaries of KS2 and KS4 were chosen as fusion sites (Figure S2).
The extended PCR fragment was introduced into E. coli BW25113/pIJ790
harboring pYU50 (see the section on construction of har PKS) to replace the
target gene region for a spectinomycin resistance cassette. A resulting
plasmid pYU67 was digested with AvrII and religated to remove the resistance
cassette, yielding the expression plasmid pYU69 for the aur# PKS.
Construction of the har PKS Mutant
In order to delete the genes encoding between the AT2 and KS3 domains, two
primers KS2_fw_HpaI (50-AAC GCC CAT GTC ATC CTG GAA CAG GCC GAG
CAG CCC CCG GTT AAC GGA ACT TCG AAG TTC CCG CC-30) and
KS4_rv_HpaI (50-CGG GAT GTC CGC GCC CTC CGG CCC GTC CGT CAT
CTC CCC GTT AAC GGA ATA GGA ACT TCA TGA GC-30) were designed
and a spectinomycin resistance cassette flanked by HpaI restriction sites
was amplified from pIJ778 as a template. Boundaries of KS2-AT2 linker and
KS3-AT3 linker were chosen as fusion sites (Figure S2). A 1.4 kb fragment
was used to transform E. coli BW25113/pIJ790 harboring pYU31. Replace-
ment of the target gene region with the resistance cassette was achieved by
lRED-mediated recombination. An 8.7 kb EcoRI-EcoRV fragment from the re-
sulting plasmid (pYU35) was introduced into E. coli BW25113/pIJ790 contain-
ing pNT87, which gave construct pYU49 after recombination. To remove the
resistance cassette, pYU49 was restricted by HpaI and religated. Finally, an
expression plasmid pYU50 was obtained.
General Analytical Procedures
NMR spectra were measured on either a Bruker Avance DRX 500 MHz or 600
MHz spectrometer (600MHzwith a cryoprobe) in CDCl3 at 300 K. Spectrawere
referenced to the residual solvent peak. UV spectra were obtained on a Shi-
madzu UV-1800 spectrophotometer. Optical rotation was obtained by JASCO
P-1020 polarimeter. CD spectra were measured on a JASCO J-815 CD spec-
trometer. High-resolution electrospray ionization mass spectrometry and LC-
HRMS measurements were carried out on a Thermo Fisher Scientific Exactive
Orbitrap with an electrospray ion source using a Betasil 100-3 C18 column
(150 3 2.1 mm) and an elution gradient (solvent A, H2O + 0.1% HCOOH; sol-
vent B, acetonitrile; gradient, 5% B for 1 min, 5% to 98% B in 15 min, 98%
B for 3 min; flow rate, 0.2ml min1). LC-MSmeasurements for the LC chromato-
gram were carried out on a Hewlett Packard 1100 Series using an OD-5-100/
253-Reversed-Phase C18 column from SMT and an elution gradient (solvent A,
H2O + 0.1% HCOOH; solvent B, acetonitrile; gradient, 0.5% to 99.5% B in
37 min, 99.5% B for 1 min, 99.5% to 0.5% in 2 min; flow rate, 0.8 ml min1).
Antimicrobial Assays
Sterile filter paper disks were impregnated with 50 mg of the samples using
methanol as the carrier solvent. The impregnated disks were then placed on
agar plates previously inoculated with Bacillus subtilis ATCC 6633, Mycobac-
terium vaccae IMET 10670,Pseudomonas aeruginosaK799/61,Pseudomonas
aeruginosa SG137/B7, Staphylococcus aureus SG511, Staphylococcus
aureus 134/94 R9 (MRSA), Enterococcus faecalis 1528 R10 (vancomycin-
resistant enterococci), Escherichia coli SG458, Sporobolomyces salmonicolor
SBUG 549,Candida albicans, and Penicillium notatum JP36. Chloramphenicol
and amphotericin were used as positive controls against bacteria and fungi,
respectively. MeOHwas used as a negative control. After the plates were incu-
bated at 37C for 24 hr, antimicrobial activity was recorded as clear zones
(in millimeters) of inhibition surrounding the disk. The test sample was consid-
ered active when the zone of inhibition was greater than 7 mm.
Antiproliferative and Cytotoxic Assays
Cells of HUVEC (ATCCCRL-1730), K-562 (DSMACC 10), and HeLa (DSMACC
57) were grown in DMEM (CAMBREX 12-614F) and RPMI 1640 (CAMBREX–240, February 19, 2015 ª2015 Elsevier Ltd All rights reserved 237
12-167F), respectively. The media were supplemented with 10 ml l1 ultraglut-
amine 1 (Cambrex 17-605E/U1), 550 ml l1 (50 mg ml1) gentamicin sulfate
(CAMBREX 17-518Z), and 10% heat-inactivated fetal bovine serum (PAA
A15-104) at 37C in high-density polyethylene flasks (NUNC 156340). The cells
were incubated with dilutions of the compounds in microplates for 72 hr at
37C in a humidified atmosphere and 5% CO2. For the proliferation assay,
the test substances were dissolved in DMSO before being diluted in DMEM.
The adherent cells were harvested at the logarithmic growth phase after soft
trypsinization using 0.25% trypsin in PBS containing 0.02% EDTA (Biochrom
KG L2163). For each experiment, approximately 10,000 cells were seeded
with 0.1 ml of culture medium per well of the 96-well microplates (HUVEC,
flat-bottomed NUNC 167008; K-562, round-bottomed NUNC 163320). To
test the antiproliferative effect of natural products on HUVEC and K-562, the
cells were incubated for 72 hr in plates prepared with control and different di-
lutions of test substances. The GI50 values were defined as being where the in-
hibition of proliferation was 50% compared with the untreated control. For the
cytotoxicity assay, HeLa cells were preincubated for 48 hr without the test sub-
stances. To test the cytotoxic effect of natural products on HeLa, the dilutions
of the compounds were carried out carefully on the subconfluent monolayers
of HeLa cells after the preincubation time. After the incubation time, the cyto-
lytic effect of the compounds was analyzed compared with the negative
control. The 50% cytotoxicity concentration (CC50) was defined as the test
compound concentration required for destruction of 50%of the cell monolayer
compared with the untreated control. For estimating the influence of natural
products on cell proliferation of K-562, we determined the number of viable
cells present in multiwell plates via the CellTiter-Blue assay (PROMEGA).
This assay uses the indicator dye resazurin to measure the metabolic capacity
of cells as an indicator of cell viability. Viable cells of untreated control retain
the ability to reduce resazurin into resorufin, whereas nonviable cells rapidly
lose metabolic capacity and do not reduce the indicator dye. The absorption
maximum for resazurin is 605 nm and the absorption maximum for resorufin
is 573 nm. Thus, the absorbance measurements at 570 nm and using
600 nm as a reference wavelength can be used to monitor results. Values
are compared with a blank well containing CellTiter-Blue reagent without cells.
The adherent HUVEC and HeLa cells were fixed by glutaraldehyde (MERCK
1.04239.0250) and stained with a 0.05% solution of methylene blue (SERVA
29198) for 15 min. After gentle washing, the stain was eluted with 0.2 ml of
0.33 N HCl in the wells. The optical densities were measured at 660 nm (meth-
ylene blue) or at 570 nm (600 nm) in a SUNRISE microplate reader (TECAN).
Under our experimental conditions, the signals from the methylene blue and
CellTiter-Blue reagent are proportional to the number of viable cells. A repeat
determination was conducted for all experiments and four replicates were as-
sayed. The calculations of the different values of GI50 and CC50 were per-
formed with Magellan software (TECAN).
Isolation of Homoneoaureothin, 5
Mycelium ofStreptomyces lividansZX1::pNT42, pNT87, pYU01 from a 20 l cul-
ture was extracted with methanol (2 l). After the solvent was removed under
reduced pressure, the extract was subjected to silica gel column chromatog-
raphy (5 3 23 cm, silica gel 60, 0.040–0.063 mm) using a dichloromethane/
methanol gradient. Two fractions that contained 1 and 5 were subjected to
preparative RP-HPLC (Eurosphere C18, 20 3 250 mm, flow rate 12 ml
min1) using a gradient of solvents A (40% acetonitrile) and B (100% acetoni-
trile), 0% B in 10 min to 100% B in 30 min and kept for 15 min, to yield 1 (111.7
and 110.2 mg) and a fraction containing 5. This fraction was subjected to pre-
parative RP-HPLC (Phenomenex fusion RP, 20 3 250 mm, flow rate 12 ml
min1) using a gradient of solvents A (60% acetonitrile) and B (100% acetoni-
trile), 0% B in 10 min to 100% B in 20 min and kept for 15 min, to obtain crude
homoneoaureothin. Further purification by semipreparative RP-HPLC (Phe-
nomenex phenylhexyl, 10 3 250 mm, flow rate 6 ml min1) yielded pure 5
(0.5 mg). The supernatant from 20 l of Streptomyces lividans ZX1::pNT42,
pNT87, pYU01 was extracted with ethyl acetate (40 l). After the solvent was
removed under reduced pressure, the residue was subjected to silica gel col-
umn chromatography (5 3 10 cm, Silica gel 60, 0.040–0.063 mm) using a di-
chloromethane/methanol gradient. The neoaureothin-containing fractions
were combined and then subjected to silica gel column chromatography
(3 3 8 cm, LiChroprep Si60, 0.015–0.025 mm) using a chloroform/methanol
gradient. Fractions enriched with the target compound were subjected to pre-238 Chemistry & Biology 22, 229–240, February 19, 2015 ª2015 Elseparative RP-HPLC (Phenomenex fusion RP, 20 3 250 mm, flow rate 12 ml
min1) using a gradient of solvents A (60% acetonitrile) and B (100% acetoni-
trile), 0% B in 10 min to 100% B in 20 min and kept for 15 min, to yield 1
(130.1 mg).
Isolation of Homoaureothin, 6
Mycelium of Streptomyces lividans ZX1::pNT42/pYU50/pYU01 from a 20 l cul-
ture was extracted with methanol (40 l). After the solvent was removed under
reduced pressure, the extract was subjected to silica gel column chromatog-
raphy (5 3 23 cm, silica gel 60, 0.040–0.063 mm) using a dichloromethane/
methanol gradient. A homoaureothin-containing fractionwas further subjected
to preparative RP-HPLC (Eurosphere C18, 20 3 250 mm, flow rate 12 ml
min1) using a gradient of solvents A (40% acetonitrile) and B (100% acetoni-
trile), 0% B in 10 min to 100% B in 30 min and kept for 15 min, to yield crude
homoaureothin and trace amounts of neoaureothin (1, <0.1 mg). Crude homo-
aureothin was subjected to preparative RP-HPLC (Phenomenex fusion RP,
20 3 250 mm, flow rate 12 ml min1) using a gradient system of solvents A
(60% acetonitrile) and B (100% acetonitrile), 0% B in 10 min to 100% B in
20 min and kept for 15 min, to yield 6 (6.6 mg).
Homoneoaureothin, 5
Yellow amorphous solid; HRMS: [M + H]+ = 518.2541 (calculated for
C31H36NO6 518.2537); UV (MeOH) lmax= 261 (ε 5,300), 363 (sh, ε 2,700);
NMR data see Table S1.
Homoaureothin, 6
Yellow amorphous solid; HRMS: [M + H]+ = 438.1917 (calculated for C25H28
NO6 438.1911); UV (MeOH) lmax= 267 (ε 4,300), 360 (ε 3,400); [a]D
25 = +73
(c 0.1, CHCl3); NMR data see Table S1.
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